Dalidnetug is a humanized monoclonal antibody targeting human amyloid-beta precursor protein (APP). Dalidnetug specifically binds to APP to reduce the production of amyloid-beta (Abeta), thus exerting the activity of clearing amyloid-beta. Dalidnetug is promising for research of Alzheimers disease[1].
Molecular Weight:
(146.524 kDa)
Purity:
96.686
CAS Number:
[2991369-43-6]
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted